Business Description
Jaguar Health is a San Francisco-based pharmaceutical company that develops plant-derived medicines to treat gastrointestinal conditions in both humans and animals. Its flagship products include Mytesi, approved to relieve diarrhea in HIV/AIDS patients on antiretroviral therapy, and Canalevia-CA1, designed to address chemotherapy-induced diarrhea in dogs. The company is advancing several additional treatments through clinical trials, targeting conditions such as irritable bowel syndrome, short bowel syndrome, and cancer therapy-related diarrhea.
